Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Genasys Inc.ex_247604.htm
EX-31.2 - EXHIBIT 31.2 - Genasys Inc.ex_247603.htm
EX-31.1 - EXHIBIT 31.1 - Genasys Inc.ex_247602.htm
 


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


 

(Mark one)

☒         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2021

 

or

 

☐         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                          to                           .

 

Commission File Number: 000-24248


lrad20210331_10qimg001.gif

GENASYS INC.

(Exact name of registrant as specified in its charter)


Delaware

87-0361799

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

   

16262 West Bernardo Drive, San Diego,

California

92127

(Address of principal executive offices)

(Zip Code)

 

(858) 676-1112

(Registrants telephone number, including area code)


 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which securities are registered

Common stock, $0.00001 par value per share

GNSS

NASDAQ Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒   Yes     ☐  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer

Accelerated filer

         
 

Non-accelerated filer

Smaller reporting company

         
  Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ☐  Yes  ☒    No

 

The number of shares of Common Stock, $0.00001 par value, outstanding on May 11, 2021 was 33,849,566.



 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1.         Financial Statements

 

 

Genasys Inc.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value and share amounts)

 

   

March 31,

         
   

2021

   

September 30,

 
   

(Unaudited)

   

2020

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 18,455     $ 23,319  

Short-term marketable securities

    5,474       4,265  

Restricted cash

    282       282  

Accounts receivable, net

    5,445       5,442  

Inventories, net

    6,451       5,949  

Prepaid expenses and other

    1,082       860  

Total current assets

    37,189       40,117  
                 

Long-term marketable securities

    2,450       3,805  

Long-term restricted cash

    1,190       395  

Deferred tax assets, net

    10,817       11,095  

Property and equipment, net

    1,901       1,930  

Goodwill

    8,380       2,472  

Intangible assets, net

    3,570       943  

Operating lease right of use asset

    5,216       5,285  

Other assets

    195       125  

Total assets

  $ 70,908     $ 66,167  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Accounts payable

  $ 2,555     $ 1,370  

Accrued liabilities

    6,994       7,880  

Notes payable, current portion

    300       300  

Operating lease liabilities, current portion

    859       771  

Total current liabilities

    10,708       10,321  
                 

Notes payable, less current portion

    -       18  

Other liabilities, noncurrent

    884       293  

Operating lease liabilities, noncurrent

    6,172       6,395  

Total liabilities

    17,764       17,027  
                 

Stockholders' equity:

               

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding

    -       -  

Common stock, $0.00001 par value; 100,000,000 shares authorized; 33,849,566 and 33,561,544 shares issued and outstanding, respectively

    -       -  

Additional paid-in capital

    95,218       91,248  

Accumulated deficit

    (42,215 )     (41,858 )

Accumulated other comprehensive income (loss)

    141       (250 )

Total stockholders' equity

    53,144       49,140  

Total liabilities and stockholders' equity

  $ 70,908     $ 66,167  

 

See accompanying notes

 

1

 

Genasys Inc.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(Unaudited)

 

   

Three months ended

   

Six months ended

 
   

March 31,

   

March 31,

 
   

2021

   

2020

   

2021

   

2020

 

Revenues:

                               

Product sales

  $ 10,131     $ 7,553     $ 17,081     $ 15,561  

Contract and other

    1,170       723       2,248       1,497  

Total revenues

    11,301       8,276       19,329       17,058  

Cost of revenues

    5,964       4,266       10,288       8,446  
                                 

Gross Profit

    5,337       4,010       9,041       8,612  
                                 

Operating expenses

                               

Selling, general and administrative

    3,824       2,732       7,155       5,554  

Research and development

    960       949       2,026       2,033  

Total operating expenses

    4,784       3,681       9,181       7,587  
                                 

Income (loss) from operations

    553       329       (140 )     1,025  
                                 

Other income (expense), net

    (8 )     70       61       166  
                                 

Income (loss) before income taxes

    545       399       (79 )     1,191  

Income tax expense

    283       97       278       269  

Net income (loss)

  $ 262     $ 302     $ (357 )   $ 922  
                                 

Net income (loss) per common share - basic and diluted

  $ 0.01     $ 0.01     $ (0.01 )   $ 0.03  

Weighted average common shares outstanding:

                               

Basic

    33,683,240       33,094,596       33,629,479       33,036,786  

Diluted

    34,779,266       33,732,619       33,629,479       33,708,832  

 

 

See accompanying notes

 

2

 

Genasys Inc.

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(in thousands)

(Unaudited)

 

   

Three months ended

   

Six months ended

 
   

March 31,

   

March 31,

 
   

2021

   

2020

   

2021

   

2020

 

Net income (loss)

  $ 262     $ 302     $ (357 )   $ 922  

Other comprehensive income

                               

Unrealized (loss) on marketable securities

    (3 )     (8 )     (6 )     (11 )

Unrealized foreign currency gain (loss)

    (75 )     (62 )     397       27  

Comprehensive income

  $ 184     $ 232     $ 34     $ 938  

 

3

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

   

Six months ended

 
   

March 31,

 
   

2021

   

2020

 

Operating Activities:

               

Net (loss) income

  $ (357 )   $ 922  
                 

Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:

         

Depreciation and amortization

    552       415  

Amortization of debt issuance costs

    2       -  

Warranty provision

    37       (11 )

Inventory obsolescence

    196       128  

Share-based compensation

    510       454  

Realized loss on foreign currency forward contract

    (48 )     -  

Unrealized loss on foreign currency forward contract

    (28 )     -  

Deferred income taxes

    278       269  

Amortization of operating lease right of use asset

    343       292  

Accretion of acquisition holdback liability

    22       -  
                 

Changes in operating assets and liabilities:

               

Accounts receivable, net

    (14 )     (2,205 )

Inventories, net

    (698 )     (1,214 )

Prepaid expenses and other

    (253 )     787  

Accounts payable

    1,184       1,072  

Accrued and other liabilities

    (1,363 )     (3,036 )

Net cash provided by (used in) operating activities

    363       (2,127 )
                 

Investing Activities:

               

Purchases of marketable securities

    (2,799 )     (2,013 )

Proceeds from maturities of marketable securities

    2,939       1,971  

Cash paid for Amika Mobile

    (4,367 )     -  

Capital expenditures

    (148 )     (102 )

Net cash used in investing activities

    (4,375 )     (144 )
                 

Financing Activities:

               

Proceeds from exercise of stock options

    170       258  

Repurchase of common stock

    -       (398 )

Shares retained for payment of taxes in connection with settlement of restricted stock units

    (141 )     (41 )

Payments on promissory notes

    (18 )     (17 )

Cash paid for debt issuance costs

    (38 )     -  

Net cash used in financing activities

    (27 )     (198 )

Effect of foreign exchange rate on cash

    (30 )     11  

Net decrease in cash, cash equivalents, and restricted cash

    (4,069 )     (2,458 )

Cash, cash equivalents and restricted cash, beginning of period

    23,996       19,517  

Cash, cash equivalents and restricted cash, end of period

  $ 19,927     $ 17,059  
                 

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:

               

Cash and cash equivalents

  $ 18,455     $ 16,399  

Restricted cash, current portion

    282       265  

Long-term restricted cash

    1,190       395  

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

  $ 19,927     $ 17,059  

 

 

See accompanying notes

 

4

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in thousands)

(Unaudited)

 

   

Six months ended March 31,

 
   

2021

   

2020

 

Noncash investing and financing activities:

               

Change in unrealized gain (loss) on marketable securities

  $ (6 )   $ (11 )

Obligation to issue common stock in connection with the purchase of Amika Mobile

  $ (3,431 )   $ -  

Initial measurement of operating lease right of use assets

  $ 259     $ 5,824  

Initial measurement of operating lease liabilities

  $ 259     $ 7,815  
                 

Business combination accounted for as a purchase

               

Fair value of asset purchase holdback liability

  $ 613     $ -  

 

 
5

(in thousands, except per share and share amounts)

(Unaudited)

 

 

1. OPERATIONS

 

Genasys Inc. (formerly LRAD® Corporation), a Delaware corporation (the “Company”), is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products, and location-based mass messaging solutions for emergency warning and workforce management. The principal markets for the Company’s proprietary sound reproduction technologies, voice broadcast products and mass messaging solutions are in North and South America, Europe, the Middle East and Asia. On October 23, 2019, the Company announced its rebranding and began doing business as Genasys Inc.

 

 

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

General

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30, 2020 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on December 10, 2020. The accompanying condensed consolidated balance sheet at September 30, 2020 has been derived from the audited consolidated balance sheet at September 30, 2020 contained in the above referenced Form 10-K. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Principles of Consolidation

 

The Company has seven wholly owned subsidiaries, Genasys II Spain, S.A.U (“Genasys Spain”), Genasys Communications Canada ULC, Genasys Singapore PTE Ltd, Genasys Puerto Rico, LLC and Genasys Inc. (branch) in the United Arab Emirates and two currently inactive subsidiaries, Genasys America de CV and LRAD International Corporation. The condensed consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Cash, cash equivalents and restricted cash

 

The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. As of March 31, 2021, the amount of cash and cash equivalents was $18,455. As of September 30, 2020, the amount of cash and cash equivalents was $23,319.

 

The Company considers any amounts pledged as collateral or otherwise restricted for use in current operations to be restricted cash. In addition, the Company excludes from cash and cash equivalents cash required to fund specific future contractual obligations related to business combinations. Restricted cash is classified as a current asset unless amounts are not expected to be released and available for use in operations within one year. As of March 31, 2021, the current portion of restricted cash was $282 and the noncurrent portion was $1,190. As of September 30, 2020, the current portion of restricted cash was $282 and the noncurrent portion was $395.

 

Immaterial Correction of Prior Period Financial Statements

 

During the quarter ended December 31, 2020, Company management identified an immaterial error in the previously issued September 30, 2020 consolidated balance sheet. This error resulted in an overstatement of prepaid expenses and accrued liabilities of $5,205 related to a foreign currency forward contract which was presented on a gross basis rather than on a net basis. There was no impact to the consolidated statement of operations or the consolidated statement of cash flows as of September 30, 2020, as a result of this misstatement. Further, there was no impact to the condensed consolidated financial statements as of, and for the six months ended March 31, 2021, as the forward contract was settled during the first quarter of fiscal 2021.  SEC Staff Accounting Bulletin: No. 99 – Materiality and No. 108 – Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements were used by management to evaluate the impact of the misstatement. Management concluded that this misstatement had no material impact on either the accompanying condensed consolidated balance sheet as of March 31, 2021 or the previously issued consolidated balance sheet as of September 30, 2020, and therefore the misstatement was corrected in the accompanying condensed consolidated balance sheet as of September 30, 2020. All financial information contained in the accompanying notes to these condensed consolidated financial statements has been revised to reflect the correction of this error.

 

Reclassifications

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

 

6

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

3. RECENT ACCOUNTING PRONOUNCEMENTS

 

New pronouncements pending adoption

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets, including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No. 2019-10, Financial Instruments Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842), which extends the effective date of Topic 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of its fiscal year beginning October 1, 2023, and early adoption is permitted. The Company has not completed its review of the impact of this standard on its consolidated financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, management does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU No. 2020-04 provides optional guidance, expedients and exceptions for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update apply to all entities, subject to meeting the criteria, which participate in contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. ASU No. 2020-04 was subsequently amended by ASU No. 2021-01, Reference Rate Reform (Topic 848), Scope, which refines the scope of Topic 848 and permits optional expedients and exceptions when accounting for derivative contracts and certain hedging relationships. The amendments of these updates are available to all entities as of March 12, 2020 through December 31, 2022. The Company has not yet adopted these amendments. The Company’s management does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

New pronouncements adopted

 

In August 2018, the FASB issued ASU No. 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves fair value disclosure requirements by removing disclosures that are not cost beneficial, clarifying disclosures’ specific requirements and adding relevant disclosure requirements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The new guidance is effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted ASU No. 2018-13 on October 1, 2020, with no impact to the condensed consolidated financial statements.

 

 

4.

BUSINESS COMBINATION

 

On October 2, 2020, the Company completed the purchase of the assets of Amika Mobile Corporation (“Amika Mobile”) pursuant to an Asset Purchase Agreement. Amika Mobile is a leading provider of integrated emergency critical communications based in Ottawa, Canada. The Company believes the Amika Mobile asset purchase will expand the Company’s enterprise software solutions and enhance the Company’s unified multi-channel critical communications platform.

 

The Amika Mobile asset purchase was accounted for as a business combination using the acquisition method pursuant to ASC Topic 805. As the acquirer for accounting purposes, the Company has estimated the purchase consideration, assets acquired and liabilities assumed as of the acquisition date, with the excess of the purchase consideration over the fair value of net assets acquired recognized as goodwill. The estimated fair value of assets purchased and liabilities assumed in certain cases may be subject to revision based on the final determination of fair value.

 

The consideration consisted of the following:

 

Cash paid

  $ 4,367  

Asset purchase holdback liability

    613  

Common stock to be issued

    3,431  
    $ 8,411  

 

7

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Under the terms of the Asset Purchase Agreement, the Company is required to deposit a holdback liability in the amount of CAD$1,000 into an interest-bearing account as security for potential indemnification claims against the seller. The holdback amount will be released three years from the closing date subject to amounts withheld for actual, pending or potential claims. The Company also agreed to issue 191,267 shares of the Company’s common stock to the seller of the Amika Mobile assets on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in an addition of $3,431 to additional paid-in-capital. The cash portion of the purchase price was funded from cash on hand.

 

The Company incurred $264 in expenses related to this transaction through March 31, 2021. These expenses were recorded in selling, general and administrative expenses in the condensed consolidated statement of operations as follows: $22 in the second quarter of fiscal 2021, $10 in the first quarter of fiscal 2021, $132 in the fourth quarter of fiscal 2020 and $100 in the third quarter of fiscal 2020.

 

Purchase Price Allocation

 

Assets Acquired

       

Prepaid expenses

  $ 2  

Fixed assets

    22  

Operating lease right of use asset

    248  

Intangible Assets

    2,820  

Goodwill

    5,590  

Total assets acquired

  $ 8,682  
         

Liabilities assumed

       

Accrued liabilities

  $ 23  

Operating lease liability

    248  

Total liabilities assumed

    271  

Net Assets acquired

  $ 8,411  

 

The estimated fair value of the identifiable intangible assets acquired and their estimated useful lives are as follows:

 

   

Fair Value

   

Useful Lives (in years)

 

Developed technology

  $ 2,500       7  

Customer relationships

    320       7  
    $ 2,820          

 

Identifiable intangible assets consist of certain technology and customer relationships purchased from Amika Mobile. Identifiable intangible assets are amortized over their useful lives based upon a number of assumptions, including the estimated period of economic benefit and utilization. The weighted average amortization period for identifiable intangible assets acquired is 7 years. These intangible assets are classified as Level 3 in the ASC topic 820 three-tier fair value hierarchy.

 

The goodwill for Amika Mobile is attributable to combining the Company’s existing emergency communications solutions with the software and software development capabilities of Amika Mobile to enhance product offerings. Goodwill is also attributable to the skill level of the acquired workforce. The Company will continue to analyze the transaction and refine its calculations, as appropriate during the measurement period, which could affect the value of goodwill. Goodwill from the Amika Mobile asset purchase will not be deductible for tax purposes.

 

 
 

5.

REVENUE RECOGNITON

 

The Company adopted the guidance in Topic 606 on October 1, 2018. The Company adopted the new standard using the full retrospective approach.

 

Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized:

 

 

1.

Identify the contract(s) with customers

 

2.

Identify the performance obligations

 

8

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

3.

Determine the transaction price

 

4.

Allocate the transaction price to the performance obligations

 

5.

Recognize revenue when the performance obligations have been satisfied

 

Topic 606 requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services.

 

The Company derives its revenue from the sale of products to customers, contracts, license fees, other services and freight. The Company sells its products through its direct sales force and through authorized resellers and system integrators. The Company recognizes revenue for goods including software when all the significant risks and rewards have been transferred to the customer, no continuing managerial involvement usually associated with ownership of the goods is retained, no effective control over the goods sold is retained, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transactions will flow to the Company, and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Software license revenue, maintenance and/or software development service fees may be bundled in one arrangement or may be sold separately.

 

Product Revenue

 

Product revenue is recognized as a distinct single performance obligation when products are tendered to a carrier for delivery, which represents the point in time that the Company’s customer obtains control of the products. A smaller portion of product revenue is recognized when the customer receives delivery of the products. A portion of products are sold through resellers and system integrators based on firm commitments from an end user, and as a result, resellers and system integrators carry little or no inventory. The Company’s customers do not have a right to return product unless the product is found defective and therefore the Company’s estimate for returns has historically been insignificant

 

Perpetual licensed software

 

The sale and/or license of software products is deemed to have occurred when a customer either has taken possession of, or has the ability to take immediate possession of, the software and the software key. Perpetual software licenses can include one-year maintenance and support services. In addition, the Company sells maintenance services on a stand-alone basis and is therefore capable of determining their fair value. On this basis, the amount of the embedded maintenance is separated from the fee for the perpetual license and is recognized on a straight-line basis over the period to which the maintenance relates.

 

Time-based licensed software

 

The time-based license agreements include the use of a software license for a fixed term, generally one-year, and maintenance and support services during the same period. The Company does not sell time-based licenses without maintenance and support services and therefore revenues for the entire arrangements are recognized on a straight-line basis over the term.

 

Warranty, maintenance and services

 

The Company offers extended warranty, maintenance and other services. Extended warranty and maintenance contracts are offered with terms ranging from one to several years, which provide repair and maintenance services after expiration of the original one-year warranty term. Revenues from separately priced extended warranty and maintenance contracts are recognized based on time elapsed over the service period and classified as contract and other revenues. Revenue from other services such as training or installation is recognized when the service is completed.

 

Multiple element arrangements

 

The Company has entered into a number of multiple element arrangements, such as the sale of a product or perpetual licenses that may include maintenance and support (included in the price of perpetual licenses) and time-based licenses (that include embedded maintenance and support, both of which may be sold with software development services, training, and other product sales). In some cases, the Company delivers software development services bundled with the sale of the software. In multiple element arrangements, the Company uses either the stand-alone selling price or an expected cost plus margin approach to determine the fair value of each element within the arrangement, including software and software-related services such as maintenance and support. In general, elements in such arrangements are also sold on a stand-alone basis and stand-alone selling prices are available.

 

Revenue is allocated to each deliverable based on the relative stand-alone selling price of each individual element and is recognized when the revenue recognition criteria described above are met, except for time-based licenses which are not unbundled. When software development services are performed and are considered essential to the functionality of the software, the Company recognizes revenue from the software development services on a stage of completion basis, and the revenue from the software when the related development services have been completed.

 

9

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

The Company disaggregates revenue by reporting segment (Hardware and Software) and geographically to depict the nature of revenue in a manner consistent with the Company’s business operations and to be consistent with other communications and public filings. Refer to Note 19, Segment Information and Note 20, Major Customers, Suppliers and Related Information for additional details of revenues by reporting segment and disaggregation of revenue.

 

Contract Assets and Liabilities

 

The Company enters into contracts to sell products and provide services and recognizes contract assets and liabilities that arise from these transactions. The Company recognizes revenue and corresponding accounts receivable according to Topic 606 and, at times, recognizes revenue in advance of the time when contracts give the Company the right to invoice a customer. The Company may also receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below shows the balance of contract assets and liabilities as of March 31, 2021 and September 30, 2020, including the change between the periods. The current portion of contract liabilities and the non-current portion are included in “Accrued liabilities” and “Other liabilities, noncurrent”, respectively, on the accompanying Condensed Consolidated Balance Sheets. Refer to Note 11, Accrued Liabilities for additional details.

 

The Company’s contract liabilities were as follows:

 

   

Customer

deposits

   

Deferred

revenue

   

Total contract

liabilities

 

Balance at September 30, 2020

  $ 3,683     $ 1,024     $ 4,707  

New performance obligations

    5,065       584       5,649  

Recognition of revenue as a result of satisfying performance obligations

    (5,579 )     (785 )     (6,364 )

Effect of exchange rate on deferred revenue

    -       11       11  

Balance at March 31, 2021

  $ 3,169     $ 834     $ 4,003  

Less: non-current portion

    -       (214 )     (214 )

Current portion at March 31, 2021

  $ 3,169     $ 620     $ 3,789  

 

Remaining Performance Obligations

 

Remaining performance obligations related to Topic 606 represent the aggregate transaction price allocated to performance obligations under an original contract with a term greater than one year, which are fully or partially unsatisfied at the end of the period.

 

As of March 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $4,003. The Company expects to recognize revenue on approximately $3,789 or 95% of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter.

 

Practical Expedients 

 

In cases where the Company is responsible for shipping after the customer has obtained control of the goods, the Company has elected to treat these activities as fulfillment activities rather than as a separate performance obligation. Additionally, the Company has elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. The Company only gives consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year. The Company also utilizes the “as invoiced” practical expedient in certain cases where performance obligations are satisfied over time and the invoiced amount corresponds directly with the value the Company is providing to the customer.

 

 
 

6.

FAIR VALUE MEASUREMENTS

 

The Company’s financial instruments consist principally of cash equivalents, short and long-term marketable securities, accounts receivable and accounts payable. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

  Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

   

10

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

  Level 2:  Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.
     
  Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the Company’s cash equivalents and marketable securities was determined based on Level 1 and Level 2 inputs. The Company did not have any marketable securities in the Level 3 category as of March 31, 2021 or September 30, 2020. The Company believes that the recorded values of its other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

 

Instruments Measured at Fair Value on a Recurring Basis

 

Cash equivalents and marketable securities: The following tables present the Company’s cash equivalents and marketable securities’ costs, gross unrealized gains and losses, and fair value by major security type recorded as cash equivalents or short-term or long-term marketable securities as of March 31, 2021 and September 30, 2020. Unrealized gains and losses from the remeasurement of marketable securities are recorded in accumulated other comprehensive income (loss) until recognized in earnings upon the sale or maturity of the security.

 

   

March 31, 2021

 
   

Cost Basis

   

Unrealized Gain

   

Fair Value

   

Cash Equivalents

   

Short-term Securities

   

Long-term Securities

 

Level 1:

                                               

Money Market Funds

  $ 538     $ -     $ 538     $ 538     $ -     $ -  
                                                 

Level 2:

                                               

Certificates of deposit

    1,193       -       1,193       -       251       942  

Municipal securities

    5,223       1       5,224       -       4,161       1,063  

Corporate bonds

    1,507       -       1,507       -       1,062       445  

Subtotal

    7,923       1       7,924       -       5,474       2,450  
                                                 

Total

  $ 8,461     $ 1     $ 8,462     $ 538     $ 5,474     $ 2,450  

 

   

September 30, 2020

 
   

Cost Basis

   

Unrealized Gain

   

Fair Value

   

Cash Equivalents

   

Short-term Securities

   

Long-term Securities

 

Level 1:

                                               

Money Market Funds

  $ 365     $ -     $ 365     $ 365     $ -     $ -  
                                                 

Level 2:

                                               

Certificates of deposit

    1,195       -       1,195       -       -       1,195  

Municipal securities

    3,777       4       3,781       -       2,432       1,350  

Corporate bonds

    3,091       3       3,094       -       1,833       1,260  

Subtotal

    8,063       7       8,070       -       4,265       3,805  
                                                 

Total

  $ 8,428     $ 7     $ 8,435     $ 365     $ 4,265     $ 3,805  

 

Foreign currency forward contract: In August 2020, the Company entered into a foreign currency forward contract as an economic hedge against exposure to changes in the Canadian dollar in connection with the Amika Mobile asset purchase. At September 30, 2020, the notional value of the foreign currency forward contract was CAD$6,955 with a maturity date in October 2020. The foreign currency forward contract was classified under Level 2 of the fair value hierarchy. The valuation techniques used to measure the fair value were based on quoted market prices. On October 1, 2020, the foreign currency forward contract was settled for CAD$6,955 (USD$5,281), resulting in a realized loss of $48 on the contract that was recorded in earnings as other income (expense). The foreign currency forward contract liability was recorded in accrued liabilities in the consolidated balance sheet as of September 30, 2020.

 

11

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

7. INVENTORIES, NET

 

Inventories, net consisted of the following:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Raw materials

  $ 5,385     $ 5,220  

Finished goods

    718       841  

Work in process

    980       456  

Inventories, gross

    7,083       6,517  

Reserve for obsolescence

    (632 )     (568 )

Inventories, net

  $ 6,451     $ 5,949  

 

 

8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Office furniture and equipment

  $ 1,233     $ 1,181  

Machinery and equipment

    1,230       1,184  

Leasehold improvements

    2,150       2,056  

Construction in progress

    16       8  

Property and equipment, gross

    4,629       4,429  

Accumulated depreciation

    (2,728 )     (2,499 )

Property and equipment, net

  $ 1,901     $ 1,930  

 

Depreciation expense was $101 and $132 for the three months ended March 31, 2021 and 2020, respectively. Depreciation expense was $200 and $266 for the six months ended March 31, 2021 and 2020, respectively.

 

 

9. GOODWILL AND INTANGIBLE ASSETS

 

Goodwill is attributable to the acquisition of Genasys Spain and the Amika Mobile asset purchase and is due to combining the integrated emergency critical communications, mass messaging solutions and software development capabilities with existing hardware products for enhanced offerings and the skill level of the acquired workforces. The Company periodically reviews goodwill for impairment in accordance with relevant accounting standards. During the six months ended March 31, 2021, the Company added $5,590 in goodwill related to the Amika Mobile asset purchase. There were no impairments to goodwill during the six months ended March 31, 2021.

 

Intangible assets and goodwill related to Genasys Spain are translated from Euros to U.S. dollars at the balance sheet date. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was an increase of $4. Intangible assets and goodwill related to Amika Mobile are translated from Canadian dollars to U.S. dollars at the balance sheet date. During the six months ended March 31, 2021, the Company added $2,820 in intangible assets related to the Amika Mobile asset purchase. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was an increase of $474. The Company’s intangible assets consisted of the following:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Technology

  $ 3,297     $ 655  

Customer relationships

    965       627  

Trade name portfolio

    228       228  

Non-compete agreements

    247       247  

Patents

    72       72  
      4,809       1,829  

Accumulated amortization

    (1,239 )     (886 )
    $ 3,570     $ 943  

 

12

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Amortization expense was $169 and $74 for the three months ended March 31, 2021 and 2020, respectively. Amortization expense was $352 and $149 for the six months ended March 31, 2021 and 2020, respectively.

 

As of March 31, 2021, future amortization expense is as follows:

 

Fiscal year ending September 30, 2021 (remaining six months)

  $ 330  

2022

    658  

2023

    625  

2024

    612  

2025

    482  

Thereafter

    863  

Total estimated amortization expense

  $ 3,570  

 

 

 

10. PREPAID EXPENSES AND OTHER

 

Prepaid expenses and other current assets consisted of the following:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Deposits for inventory

  $ 52     $ 54  

Prepaid insurance

    531       264  

Dues and subscriptions

    146       151  

Trade shows and travel

    92       103  

Other

    261       288  
    $ 1,082     $ 860  

 

Deposits for inventory

 

Deposits for inventory consisted of cash payments to vendors for inventory to be delivered in the future.

 

Prepaid insurance

 

Prepaid insurance consisted of premiums paid for health, commercial and corporate insurance. These premiums are amortized on a straight-line basis over the term of the agreements.

 

Dues and subscriptions

 

Dues and subscriptions consist of payments made in advance for software subscriptions and trade and professional organizations. These payments are amortized on a straight-line basis over the term of the agreements.

 

Trade shows and travel

 

Trade shows and travel consists of payments made in advance for trade show events.

 

13

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

11. ACCRUED LIABILITIES

 

Accrued liabilities consisted of the following:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Payroll and related

  $ 2,054     $ 2,545  

Deferred revenue

    620       731  

Customer deposits

    3,169       3,683  

Accrued contract costs

    1,007       719  

Warranty reserve

    144       126  

Other

    -       76  

Total

  $ 6,994     $ 7,880  

 

Other liabilities-noncurrent consisted of the following: 

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Deferred extended warranty revenue

  $ 214     $ 293  

Asset purchase holdback liability

    670       -  

Total

  $ 884     $ 293  

 

Payroll and related

 

Payroll and related consisted primarily of accrued vacation, bonus, sales commissions and benefits.

 

Deferred Revenue

 

Deferred revenue as of March 31, 2021 included prepayments from customers for services, including extended warranty, scheduled to be performed in the twelve months ending March 31, 2022.

 

Customer Deposits

 

Customer deposits represent amounts paid by customers as a down payment on hardware orders to be delivered during the next twelve months.

 

Accrued contract costs

 

Accrued contract costs consist of accrued expenses for contracting a third-party service provider to fulfill repair and maintenance obligations required under a contract with a foreign military for units sold in the year ended September 30, 2011. Payments to the service provider will be made annually upon completion of each year of service. A new contract was signed with the customer in May 2019 to continue repair and maintenance services through May 2024. These services are being recorded in cost of revenues to correspond with the revenues for these services.

 

Warranty Reserve

 

Changes in the warranty reserve and extended warranty were as follows:

 

   

March 31,

   

September 30,

 
   

2021

   

2020

 

Beginning balance

  $ 126     $ 150  

Warranty provision

    37       16  

Warranty settlements

    (19 )     (40 )

Ending balance

  $ 144     $ 126  

 

The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period and adjusts the accrued warranty liability to an amount equal to estimated warranty expense for products currently under warranty.

 

14

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Deferred Extended Warranty Revenue

 

Deferred extended warranty revenue consists of warranties purchased in excess of the Company’s standard warranty. Extended warranties typically range from one to two years.

 

Asset purchase holdback liability

 

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to future adjustments to assets and liabilities. Adjustments of up to CAD$1,000 (USD$794) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

 

12. DEBT

 

In connection with the acquisition of Genasys Spain the Company assumed certain debts of Genasys Spain. The carrying value of the acquired debt approximates fair value. The balances of the acquired debt consist of loans with governmental agencies as of March 31, 2021. Loans with governmental agencies represent interest free debt granted by ministries within Spain for the purpose of stimulating economic development and promoting research and development. Loans with governmental agencies as of March 31, 2021 are as follows:

 

Agency

Due Date

 

Principal

   

Ministry of Economy and Competitiveness

February 2, 2022

  $ 18    

Ministry of Economy and Competitiveness

February 2, 2024

    282  

(a)

      $ 300    

 

 

(a)

This loan is secured by $282 of cash pledged as collateral by Genasys Spain, which is the current balance of the loan. This amount is included in restricted cash at March 31, 2021. The Company expects the Ministry of Economy and Competitiveness to declare the terms of the loan satisfied within the next twelve months and that the outstanding balance of the loan will be paid in full during the next twelve months. Accordingly, this has been included in the current portion of notes payable as of March 31, 2021.

 

The following is a schedule of future annual payments as of March 31, 2021:

 

2022

  $ 300  

2023

    -  

Total

  $ 300  

 

Revolving line of credit

 

On March 8, 2021, the Company entered into an agreement with MUFG Union Bank, N.A. for a $10 million revolving line of credit. Outstanding balances on the revolving line of credit bear interest at a per annum rate equal to the London Interbank Offered Rate (“LIBOR”) plus 2.25%. The agreement contains a provision for determining an alternative interest rate index in the event the LIBOR rate is no longer available. The agreement contains standard covenants, including affirmative financial covenants, such as the maintenance of a short-term liquidity ratio and a senior leverage ratio, in addition to negative covenants which limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. The maturity date of this revolving line of credit is March 31, 2023. As of March 31, 2021, there were no borrowings on the revolving line of credit. The Company incurred and capitalized $38 of issuance costs related to this revolving line of credit. These issuance costs have and will be amortized on a straight-line basis over the term of the loan.

 

 

13. LEASES

 

The Company determines if an arrangement is a lease at inception. The guidance in Topic 842 defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. The Company’s leases do not provide an implicit rate. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Additionally, the portfolio approach is used in determining the discount rate used to present value lease payments. The operating ROU asset includes any lease payments made and excludes lease incentives and initial direct costs incurred.

 

15

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

The Company entered into operating leases for office and production facilities and equipment under agreements that expire at various dates through 2028. The Company elected the package of practical expedients permitted under the new lease standard. In electing the practical expedient package, the Company is not required to reassess whether an existing or expired contract is or contains a lease, reassess the lease classification for expired or existing leases nor reassess the initial direct costs for leases that commenced before the adoption of Topic 842. The Company also elected the short-term lease exemption such that the new lease standard was applied to leases greater than one year in duration. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

For leases beginning on or after October 1, 2019, lease components are accounted for separately from non-lease components for all asset classes. Certain of the Company’s leases contain renewal provisions and escalating rental clauses and generally require the Company to pay utilities, insurance, taxes and other operating expenses. The renewal provisions of existing lease agreements were not included in the determination of the operating lease liabilities and the operating ROU assets. Variable payments such as excess usage fees on existing equipment leases were not included in the determination of the lease liabilities and the operating ROU assets as the achievement of the specified target that triggers the variable lease payment is not considered probable. In addition, the Company’s facility lease in Spain has an escalating lease clause based on a consumer price index which is considered a variable lease payment and is not included in the determination of the lease liability and operating ROU asset. A 10% increase in the index would increase the total lease liability approximately $19. The Company’s leases do not contain any residual value guarantees or material restrictive covenants.

 

Upon adoption of Topic 842 as of October 1, 2019, the Company recognized on its consolidated balance sheet an initial measurement of approximately $7,815 of operating lease liabilities, and approximately $5,824 of corresponding operating ROU assets, net of tenant improvement allowances. There was no cumulative effect adjustment to retained earnings as a result of the transition to Topic 842. The adoption of Topic 842 did not have a material impact on the Company’s consolidated statement of operations.

 

During the six months ended March 31, 2021, the Company added an additional operating ROU asset of $259 and operating lease liabilities of $259 for office space. The tables below show the operating ROU assets and liabilities as of September 30, 2020 and the balances as of March 31, 2021, including the changes during the periods.

 

   

Operating ROU assets

 

Operating lease right of use asset at September 30, 2020

  $ 5,285  

Additional operating lease right of use assets

    259  

Less amortization of operating lease right-of-use assets

    (343 )

Effect of exchange rate on operating lease right of use assets

    15  

Operating lease right of use asset at March 31, 2021

  $ 5,216  

 

 

   

Operating lease liabilities

 

Operating lease liabilities at September 30, 2020

  $ 7,166  

Additional operating lease liabilities

    259  

Less lease principal payments on operating lease liabilities

    (409 )

Effect of exchange rate on operating lease liabilities

    15  

Operating lease liabilities at March 31, 2021

    7,031  

Less non-current portion

    (6,172 )

Current portion at March 31, 2021

  $ 859  

 

16

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

As of March 31, 2021, the Company’s operating leases have a weighted-average remaining lease term of 7.11 years and a weighted-average discount rate of 4.13%. The maturities of the operating lease liabilities are as follows:

 

Fiscal year ending September 30, 2021 (remaining six months)

  $ 569  

2022

    1,141  

2023

    1,090  

2024

    1,085  

2025

    1,162  

Thereafter

    3,104  

Total undiscounted operating lease payments

    8,151  

Less imputed interest

    (1,120 )

Present value of operating lease liabilities

  $ 7,031  

 

For the three months ended March 31, 2021 and 2020, total lease expense under operating leases was approximately $245 and $224, respectively. For the six months ended March 31, 2021 and 2020, total lease expense under operating leases was approximately $490 and $448, respectively. For the three and six months ended March 31, 2021 total short-term lease expense was $2. There was no short-term lease expense during the three and six months ended March 31, 2020.

 

 

14. INCOME TAXES

 

For the six months ended March 31, 2021, the Company recorded income tax expense of $278 reflecting an effective tax rate of 22.1%. For the six months ended March 31, 2020, the Company recorded income tax expense of $269 reflecting an effective tax rate of 21.6%. The Company continues to maintain a partial valuation allowance against its deferred tax assets as the Company believes that the negative evidence that it will be able to recover these net deferred tax assets outweighs the positive evidence.

 

Accounting Standards Codification Topic 740, Accounting for Uncertainty in Income Taxes, requires the Company to recognize in its consolidated financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. If interest or penalties are assessed, the Company would recognize these charges as income tax expense. The Company has not recorded any income tax expense or benefit for uncertain tax positions.

 

 

15. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when appropriate in management’s estimation, record adequate reserves in the Company’s consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

Bonus Plan

 

The Company has a bonus plan for employees, in accordance with their terms of employment, whereby they can earn a percentage of their salary based on meeting targeted objectives for orders received, revenue, operating income and operating cash flow. In the six months ended March 31, 2021, the Company recorded $898 of bonus expense. In the six months ended March 31, 2020, the Company recorded $400 of bonus expense.

 

Amika Mobile Asset Purchase

 

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to future adjustments to assets and liabilities. Adjustments of up to CAD$1,000 (USD$794) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

The Company also agreed to issue 191,267 shares of the Company’s common stock to the former owners of Amika Mobile on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in the addition of $3,431 to additional paid-in-capital.

 

17

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

16. SHARE-BASED COMPENSATION

 

Stock Option Plans

 

At March 31, 2021, the Company had two equity incentive plans. The 2005 Equity Incentive Plan (“2005 Equity Plan”) was terminated with respect to new grants in March 2015 but remains in effect for grants issued prior to that time. The Amended and Restated 2015 Equity Incentive Plan (“2015 Equity Plan”) was adopted by the Company’s Board of Directors on December 6, 2016 and approved by the Company’s stockholders on March 14, 2017. The 2015 Equity Plan was amended by the Company’s Board of Directors on December 8, 2020 to increase the number of shares authorized for issuance from 5,000,000 to 10,000,000. On March 16, 2021, the Company’s stockholders approved a plan amendment. The 2015 Equity Plan authorizes the issuance of stock options, restricted stock, stock appreciation rights, restricted stock units and performance awards, to an aggregate of 10,000,000 new shares of common stock to employees, directors, advisors or consultants. At March 31, 2021, there were options and restricted stock units outstanding covering 92,500 and 2,956,887 shares of common stock under the 2005 Equity Plan and 2015 Equity Plan, respectively and 5,206,915 shares of common stock available for grant for a total of 8,256,302 shares of common stock currently authorized and unissued under the two equity plans.

 

Share-Based Compensation

 

The Company’s employee stock options have various restrictions that reduce option value, including vesting provisions and restrictions on transfer and hedging, among others, and are often exercised prior to their contractual maturity.

 

There were 245,000 stock options granted during the six months ended March 31, 2021. There were 1,133,727 stock options granted during fiscal 2020. The weighted average estimated fair value of employee stock options granted during the six months ended March 31, 2021 was calculated using the Black-Scholes option-pricing model with the following weighted average assumptions (annualized percentages):

 

   

Six months ended

 
   

March 31,

 
   

2021

   

2020

 

Volatility

    48.5%       44.5%  

Risk-free interest rate

    0.6%       1.4%  

Dividend yield

    0.0%       0.0%  

Expected term

    6.8       5.4  

 

Expected volatility is based on the historical volatility of the Company’s common stock over the period commensurate with the expected term of the options. The risk-free interest rate is based on rates published by the Federal Reserve Board. The contractual term of the options was seven years. The expected term is based on observed and expected time to post-vesting exercise. The expected forfeiture rate is based on past experience and employee retention data. Forfeitures are estimated at the time of the grant and revised in subsequent periods if actual forfeitures differ from those estimates. Such revision adjustments to expense will be recorded as a cumulative adjustment in the period in which the estimate is changed. The Company has not paid a dividend in fiscal 2021 and did not pay a dividend in fiscal 2020.

 

As of March 31, 2021, there was approximately $812 of total unrecognized compensation costs related to outstanding employee stock options. This amount is expected to be recognized over a weighted average period of 2.4 years. To the extent the forfeiture rate is different from what the Company anticipated, stock-based compensation related to these awards will be different from the Company’s expectations.

 

Performance-Based Stock Options

 

On August 1, 2016, the Company awarded a performance-based stock option (PVO) to purchase 750,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. At the grant date, there were 375,000 performance-based stock options assigned to performance criteria within each of fiscal 2019 and 2020. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2019 and 2020 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets.  

 

The Company determined that certain performance conditions related to the 2019 and 2020 performance criteria were achieved. 187,500 options related to the 2019 performance criteria vested and 375,000 options related to the 2020 performance criteria vested. The Company recorded a total of $459 in stock-based compensation expense for these options through September 30, 2020, in selling, general and administrative expenses in the consolidated statement of operations.

 

18

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

On October 4, 2019, the Company awarded a performance-based stock option (PVO) to purchase 800,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2022 and 2023 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets. The Company has not recorded stock-based compensation expense related to these options.

 

The Company did not grant any PVO’s during the six months ended March 31, 2021.

 

Restricted Stock Units

 

During fiscal 2018, the Board of Directors granted 93,330 restricted stock units (“RSUs”) to employees that will vest equally over three years on each of the first three anniversary dates of the grant. These were issued at a market value of $210, which will be expensed on a straight-line basis over the three-year life of the grants. 

 

During fiscal 2019, the Board of Directors granted 99,300 RSUs to employees that will vest equally over three years on each of the first three anniversary dates of the grant. These were issued at a market value of $248, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

On March 10, 2020, each member of the Board of Directors received a grant of 30,000 RSUs that vested on the first anniversary of the grant date. These were issued at a market value of $425, which were expensed on a straight-line basis through the March 10, 2021 vest date. Also, in fiscal 2020, 81,270 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $258, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

On March 16, 2021, each member of the Board of Directors received a grant of 27,883 RSUs that vested on the first anniversary of the grant date. These were issued at a market value of $1,100, which have and will be expensed on a straight-line basis through the March 16, 2022 vest date. Also, during the quarter, 107,200 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $793, which have and will be expensed on a straight-line basis over the three-year life of the grants.

 

During the six months ended March 31, 2021, the Company retained 22,073 shares of common stock to satisfy tax withholding obligations upon the vesting of RSUs issued to employees. During the six months ended March 31, 2020, the Company retained 13,063 shares of common stock to satisfy tax withholding obligations upon the vesting of RSUs issued to employees. These shares were not acquired pursuant to any repurchase plan or program.

 

Compensation expense for RSUs was $249 and $387 for the three months and six months ended March 31, 2021, respectively.. Compensation expense for RSUs was $168 and $294 for the three and six months ended March 31, 2020, respectively. As of March 31, 2021, there was approximately $1,713 of total unrecognized compensation costs related to outstanding RSUs. This amount is expected to be recognized over a weighted average period of 1.71 years.

 

A summary of the restricted stock units of the Company as of March 31, 2021 is presented below:

 

   

Number of Shares

   

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2020

    303,014     $ 2.82  

Granted 

    246,565     $ 7.68  

Released

    (223,633 )   $ 2.78  

Forfeited/cancelled

    (277 )   $ 2.26  

Outstanding March 31, 2021

    325,669     $ 6.53  

 

19

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Stock Option Summary Information

 

A summary of the activity in options to purchase the capital stock of the Company as of March 31, 2021 is presented below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

 

Outstanding September 30, 2020

    2,659,305     $ 2.56  

Granted

    245,000     $ 7.01  

Forfeited/expired

    (94,125 )   $ 1.99  

Exercised

    (86,462 )   $ 1.97  

Outstanding March 31, 2021

    2,723,718     $ 3.00  

Exerciseable March 31, 2021

    1,480,606     $ 2.14  

 

Options outstanding are exercisable at prices ranging from $1.31 to $8.03 per share and expire over the period from 2021 to 2028 with an average life of 4.27 years. The aggregate intrinsic value of options outstanding and exercisable at March 31, 2021 was $10,137 and $6,742, respectively. The aggregate intrinsic value represents the difference between the Company’s closing stock price on the last day of trading for the quarter, which was $6.69 per share, and the exercise price multiplied by the number of applicable options. The total intrinsic value of stock options exercised during the six months ended March 31, 2021 was $455 and proceeds from these exercises were $170. The total intrinsic value of stock options exercised during the six months ended March 31, 2020 was $242 and proceeds from these exercises were $258. 

 

The following table summarized information about stock options outstanding at March 31, 2021:

 

               

Weighted Average

   

Weighted Average

           

Weighted Average

 

Range of

 

Number

   

Remaining

   

Exercise

   

Number

   

Exercise

 

Exercise Prices

 

Outstanding

   

Contractual Life

   

Price

   

Exercisable

   

Price

 

$1.31

- $1.86     334,991       2.50     $ 1.64       321,241     $ 1.64  

$1.99

- $1.99     937,500       2.94     $ 1.99       937,500     $ 1.99  

$2.16

- $3.17     72,500       0.85     $ 2.52       72,500     $ 2.52  

$3.39

- $3.40     1,133,727       5.59     $ 3.39       125,147     $ 3.40  

$6.87

- $8.03     245,000       6.71     $ 7.01       24,218     $ 6.87  
          2,723,718       4.27     $ 3.00       1,480,606     $ 2.14  

 

The Company recorded $79 and $128 of stock option compensation expense for employees, directors and consultants for the three months ended March 31, 2021, and 2020, respectively. The Company recorded $123 and $160 of stock option compensation expense for employees, directors and consultants for the six months ended March 31, 2021, and 2020, respectively.

 

Share-Based Compensation

 

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

   

Three months ended

   

Six months ended

 
   

March 31,

   

March 31,

 
   

2021

   

2020

   

2021

   

2020

 

Cost of revenues

  $ 9     $ 7     $ 15     $ 11  

Selling, general and administrative

    309       283       479       427  

Research and development

    10       6       16       16  
    $ 328     $ 296     $ 510     $ 454  

 

20

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

17. STOCKHOLDERS EQUITY

 

Summary

 

The following table summarizes changes in the components of stockholders’ equity during the six months ended March 31, 2021 and the six months ended March 31, 2020 (amounts in thousands, except par value and share amounts):

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

   

Paid-in

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Equity

 

Balance at September 30, 2020

    33,561,544     $ 336     $ 91,248     $ (41,858 )   $ (250 )   $ 49,140  

Share-based compensation expense

    -       -       182       -       -       182  

Issuance of common stock upon exercise of stock options, net

    25,899       -       54       -       -       54  

Obligation to issue common stock

    -       -       3,431       -       -       3,431  

Other comprehensive income

    -       -       -       -       469       469  

Net loss

    -       -       -       (619 )     -       (619 )

Balance at December 31, 2020

    33,587,443     $ 336     $ 94,915     $ (42,477 )   $ 219     $ 52,657  
                                                 

Share-based compensation expense

    -     $ -     $ 328     $ -     $ -     $ 328  

Issuance of common stock upon exercise of stock options, net

    60,563       1       116       -       -       116  

Issuance of common stock upon vesting of restricted stock units

    223,633       2       -       -       -       -  

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

    (22,073 )     -       (141 )     -       -       (141 )

Other comprehensive loss

    -       -       -       -       (78 )     (78 )

Net income

    -       -       -       262       -       262  

Balance at March 31, 2021

    33,849,566     $ 339     $ 95,218     $ (42,215 )   $ 141     $ 53,144  

 

                   

Additional

           

Other

   

Total

 
   

Common Stock

   

Paid-in

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Equity

 

Balance at September 30, 2019

    32,949,987     $ 330     $ 89,572     $ (53,732 )   $ (459 )   $ 35,381  

Share-based compensation expense

    -       -       158       -       -       158  

Issuance of common stock upon exercise of stock options, net

    83,343       1       144       -       -       144  

Other comprehensive loss

    -       -       -       -       85       85  

Net income

    -       -       -       620       -       620  

Balance at December 31, 2019

    33,033,330     $ 331     $ 89,874     $ (53,112 )   $ (374 )   $ 36,388  
                                                 

Share-based compensation expense

    -     $ -     $ 296     $ -     $ -     $ 296  

Issuance of common stock upon exercise of stock options, net

    56,861       -       114       -       -       114  

Issuance of common stock upon vesting of restricted stock units

    198,106       2       -       -       -       -  

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

    (13,063 )     -       (41 )     -       -       (41 )

Stock buyback

    (156,505 )     (2 )     (398 )     -       -       (398 )

Other comprehensive loss

    -       -       -       -       (69 )     (69 )

Net loss

    -       -       -       302               302  

Balance at March 31, 2020

    33,118,729     $ 331     $ 89,845     $ (52,810 )   $ (443 )   $ 36,592  

 

Common Stock Activity

 

On March 18, 2021, the Company filed an amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase the authorized number of shares of common stock of the Company from 50,000,000 to 100,000,000 shares (the “Amended Certificate”). The Amended Certificate was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders on March 16, 2021.

 

21

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

During the six months ended March 31, 2021, the Company issued 86,462 shares of common stock and received gross proceeds of $170 in connection with the exercise of stock options. During the six months ended March 31, 2020, the Company issued 140,204 shares of common stock and received gross proceeds of $258 in connection with the exercise of stock options. During the six months ended March 31, 2021, the Company issued 201,560 shares of commons stock in connection with the vesting of RSUs. During the six months ended March 31, 2020, the Company issued 185,043 shares of common stock in connection with the vesting of RSUs. 

 

In connection with the Amika Mobile asset purchase, the Company agreed to issue 191,267 shares of the Company’s common stock to the former owners of Amika Mobile on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98, resulting in the addition of $3,431 to additional paid-in-capital.

 

Share Buyback Program

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019 and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the Board of Directors extended the buyback program until December 31, 2022. The previous program expired on December 31, 2018.

 

During the six months ended March 31, 2021 no shares were repurchased by the Company. During the six months ended March 31, 2020, the Company repurchased 156,505 shares for $398.

 

Dividends

 

There were no dividends declared in the six months ended March 31, 2021 and 2020.

 

 

18. NET (LOSS) INCOME PER SHARE

 

The following table sets forth the computation of basic and diluted net income per share:

 

   

Three months ended

   

Six months ended

 
   

March 31,

   

March 31,

 
   

2021

   

2020

   

2021

   

2020

 

Net income (loss)

  $ 262     $ 302     $ (357 )   $ 922  
                                 

Basic income (loss) per share

  $ 0.01     $ 0.01     $ (0.01 )   $ 0.03  

Diluted income (loss) per share

  $ 0.01     $ 0.01     $ (0.01 )   $ 0.03  
                                 

Weighted average shares outstanding - basic

    33,683,240       33,094,596       33,629,479       33,036,786  

Assumed exercise of dilutive options

    1,096,026       638,023       -       672,046  

Weighted average shares outstanding - diluted

    34,779,266       33,732,619       33,629,479       33,708,832  
                                 

Potentially diluted securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

                               

Options

    830,000       1,602,477       2,723,718       1,602,477  

RSU

    -       -       325,669       -  

Total

    830,000       1,602,477       3,049,387       1,602,477  

 

 

19. SEGMENT INFORMATION

 

The Company is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. The Company operates in two business segments: Hardware and Software and its principal markets are North and South America, Europe, the Middle East and Asia. As reviewed by the Company’s chief operating decision maker, the Company evaluates the performance of each segment based on sales and operating income. Cash and cash equivalents, marketable securities, accounts receivable, inventory, property and equipment, deferred tax assets, goodwill and intangible assets are primary assets identified by segment. The accounting policies for segment reporting are the same for the Company as a whole.

 

22

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

The following table presents the Company’s segment disclosures:

 

   

Three months ended March 31,

   

Six months ended March 31,

 
   

2021

   

2020

   

2021

   

2020

 
                                 

Revenue from external customers

                               

Hardware

  $ 10,625     $ 7,862     $ 18,012     $ 16,221  

Software

    676       414       1,317       837  
    $ 11,301     $ 8,276     $ 19,329     $ 17,058  
                                 

Intersegment revenues

                               

Hardware

  $ -     $ -     $ -     $ -  

Software

    254       444       606       829  
    $ 254     $ 444     $ 606     $ 829  
                                 

Segment operating income (loss)

                               

Hardware

  $ 1,566     $ 523     $ 1,724     $ 1,381  

Software

    (1,013 )     (194 )     (1,864 )     (356 )
    $ 553     $ 329     $ (140 )   $ 1,025  
                                 

Other expenses:

                               

Depreciation and amortization expense

                               

Hardware

  $ 93     $ 128     $ 183     $ 259  

Software

    177       78       369       156  
    $ 270     $ 206     $ 552     $ 415  
                                 

Interest expense

                               

Hardware

  $ -     $ -     $ -     $ -  

Software

    22       -       22       -  
    $ 22     $ -     $ 22     $ -  

Income tax expense

                               

Hardware

  $ 283     $ 97     $ 278     $ 269  

Software

    -       -       -       -  
    $ 283     $ 97     $ 278     $ 269  

 

   

March 31, 2021

   

September 30, 2020

 

Long-lived assets

               

Hardware

  $ 1,888     $ 1,924  

Software

    11,963       3,421  
    $ 13,851     $ 5,345  
                 

Total assets

               

Hardware

  $ 55,933     $ 61,152  

Software

    14,975       5,015  
    $ 70,908     $ 66,167  

 

 

 

20. MAJOR CUSTOMERS, SUPPLIERS AND RELATED INFORMATION

 

For the three months ended March 31, 2021, revenues from one customer accounted for 47% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2021, revenues from one customer accounted for 49% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2021, accounts receivable from two customers accounted for 33% and 25% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

23

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

For the three months ended March 31, 2020, revenues from one customer accounted for 64% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2020, revenues from one customer accounted for 63% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2020, accounts receivable from two customers accounted for 63% and 15% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

Revenue from customers in the United States was $8,086 and $6,411 for the three months ended March 31, 2021 and 2020, respectively. Revenue from customers in the United States was $13,837 and $12,923 for the six months ended March 31, 2021 and 2020, respectively. The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location.

 

 

   

Three months ended March 31,

   

Six months ended March 31,

 
   

2021

   

2020

   

2021

   

2020

 

Americas

  $ 8,598     $ 7,046     $ 14,406     $ 13,850  

Asia Pacific

    2,213       656       3,223       2,204  

Europe, Middle East and Africa

    490       574       1,700       1,004  

Total Revenues

  $ 11,301     $ 8,276     $ 19,329     $ 17,058  

 

24

 

 

Item 2.          Managements Discussion and Analysis of Financial Condition and Results of Operations

 

The discussion and analysis set forth below should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended September 30, 2020.

 

Forward Looking Statements

 

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions - actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report and any matters set forth under Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K, which could cause actual results to differ materially from those indicated by such forward-looking statements.

 

Overview

Genasys Inc. is a global provider of critical communications hardware and software solutions designed to help keep people safe.  Our unified platform encompasses a multi-channel approach to deliver alerts, notifications, instructions, and information before, during, and after public safety and enterprise threats, critical events, and other crisis situations.

 

Our multi-channel approach includes:

 

 

LRAD® (Long Range Acoustic Device®), the world’s leading Acoustic Hailing Device (“AHD”), projects sirens and audible voice messages with exceptional vocal clarity in a 30° beam from close range to 5,500 meters.

 

 

GEM (Genasys Emergency Management) is our unified software platform for cloud, on-premise or hybrid operations that supports 2-way communications and seamlessly integrates with physical systems to initiate life-safety actions in defined geographic areas. GEM receives and manages simultaneous inputs from panic buttons, government agency or weather alert feeds, sensor events from digital thermometers, access control, fire panels, camera systems, and more. Using the information derived from the inputs, GEM delivers alerts and notifications on multiple channels, including SMS, MMS, desktop, laptop, tablet and smartphone pop-ups, social media, VoIP, callouts, public address, overhead displays, digital signs, tickers, RSS feeds, and email on any platform.

 

 

Integrated Mass Notification Systems (IMNS) span multiple hardware and software notification channels to reach at risk individuals and populations. These systems include Genasys voice arrays, which project sirens and audible voice messages 60° - 360° with industry-leading vocal clarity from close range to more than 14 square kilometers, and GEM software designed to deliver SMS, text, email, and social media alerts to people at risk in defined geographic areas. Our IMNS solutions are compatible with the Federal Emergency Management Agency (“FEMA”) Integrated Public Alert & Warning System (“IPAWS”) and other major emergency warning protocols.

 

The Company’s critical communication systems are being used in 72 countries throughout the world in a range of diverse applications, including public safety, emergency warning, mass notification, defense, law enforcement, critical event management, and many more. We continue to develop new communication innovations and believe we have significant competitive advantages in our principal markets.

 

LRAD systems represent a technological breakthrough in broadcasting audible, highly intelligible voice messages and tones over long distances and high ambient noise using minimal power. By broadcasting audible voice messages with exceptional vocal clarity and only where needed, we offer novel sound applications that conventional bullhorns, loudspeakers, public address, and emergency warning systems cannot achieve. Our LRAD systems are designed to enable users to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives. The LRAD product line is comprised of a full range of AHDs and communication solutions - from portable devices to permanently installed, remotely operated systems. We continue to expand into new markets and add new models and features to meet customer requirements.

 

Building on the success of our LRAD systems, we designed and developed our multidirectional Genasys mass notification product line. Unlike siren-only installations, our public safety mass notification hardware systems broadcast both emergency warning sirens and highly intelligible voice messages with uniform 60° - 360° coverage over local and wide areas. We believe our ability to shape the broadcast coverage area, our industry-leading speech intelligibility, and our multiple system activation and control options enable us to successfully compete in the large and growing mass notification market.

 

25

 

GEM is our cloud, on-premise or hybrid based software notification platform that enables emergency personnel, first responders, municipalities, companies, educational institutions, and government agencies to send public safety warnings and notifications to the mobile devices and desktop computers of individuals or populations in specific geographic areas with reliability, speed and ease. Alerts and notifications can be sent from a desktop or our mobile applications.

 

Genasys offers the only unified critical communications platform that provides multi-modal, geo-targeted mobile device alerts and speaker arrays that broadcast audible messages with industry-leading vocal clarity and area coverage. Our user-friendly software interface and mobile application manages and delivers notifications and information to people at risk, before, during, and after crisis situations.

 

Business developments in the fiscal quarter ended March 31, 2021:

 

 

Opened international offices in Dubai and Singapore as part of planned regional expansion

 

 

Awarded software services contract from Spain's Ministry of the Interior

 

 

Announced Government of Canada COVID vaccination tracking software project

 

 

Received multi-year enterprise software services contract from global automobile manufacturer for its operations in North America

 

 

Signed a $10 million revolving line of credit with MUFG Union Bank, N.A.

 

Revenues in the second fiscal quarter ended March 31, 2021, were $11.3 million, an increase from $8.3 million in the second fiscal quarter of 2020. The increase in revenues was driven by increases of AHD, IMNS and software revenues. AHD revenue was $9,797, an increase of $2,505 or 34%, IMNS revenue was $826, an increase of $255 or 45%, and software revenue of $676, an increase of $262 or 63%, compared to the second fiscal quarter of 2020. Based on the timing of government budget cycles, financial issues, the impact of the COVID-19 pandemic and leadership change in certain areas of the world, delays in awarding contracts often occur, resulting in uneven quarterly revenues. Gross profit increased compared to the same quarter in the prior year primarily as a result of higher sales. Operating expenses increased 30% from the prior year quarter, from $3.7 million to $4.8 million in the quarter ended March 31, 2021. The second fiscal quarter of 2021 results reflect $283 of income tax expense, compared to $97 in the prior year quarter. We reported net income of $262 for the quarter, or $0.01 per share, compared to net income of $302, or $0.01 per share, for the same quarter in the prior year.

 

Overall Business Outlook

 

Our product line-up continues to gain worldwide awareness and recognition through media exposure, product demonstrations, and word of mouth as a result of positive responses and increased acceptance of our products. We believe we have a solid global brand, technology, and product foundation with our LRAD systems and IMNS solutions, which we have expanded over the years to serve new markets and customers for greater business growth.  We believe that we have strong market opportunities for our product offerings throughout the world in the homeland security and defense sectors as a result of increasing threats to government, commerce, law enforcement, borders, and critical infrastructure. Our directional and multidirectional product offerings also have many applications within the fire rescue, public safety, maritime, asset protection, and wildlife preservation business segments.

 

The proliferation of natural disasters, crisis situations, and civil unrest require technologically advanced, multi-channel solutions to deliver clear and timely critical communications to help keep the public safe during emergencies. Businesses are also incorporating communication systems that locate and help safeguard employees when critical events occur.

 

By providing the only unified platform that combines audible, highly intelligible voice broadcast systems and mass messaging software, Genasys seeks to deliver reliable, fast, and intuitive solutions for sending location-based audible voice communications and geolocation-targeted messages and texts to mobile devices to help keep the public and workers safe.

 

Genasys has developed a global market for LRAD systems and advanced emergency warning notification solutions. We have a reputation for producing quality products that feature industry-leading vocal intelligibility and geo-targeted mass messaging. While the mass notification market is more mature with many established manufacturers and suppliers, we believe that our advanced technology and unified multi-channel platform provides opportunities to succeed in the large and growing public safety, emergency warning, and mass notification markets. We also plan to expand and strengthen domestic and international sales by opening additional sales offices in key regions and adding strategic mass notification partners, distributors, and dealers.

 

We plan to continue building on our AHD leadership position by offering enhanced directional and multidirectional voice broadcast systems and accessories for an expanding range of applications. In executing our strategy, we use direct sales to governments, militaries, large end-users, and system integrators. We have built a worldwide distribution channel consisting of partners and resellers that have significant expertise and experience selling integrated communication solutions into our various target markets. As our primary AHD sales opportunities are with domestic and international government, military, and law enforcement agencies, we are subject to each customer’s unique budget cycle, which leads to long selling cycles and uneven revenue flow, complicating our product planning. 

 

26

 

In fiscal 2021, we intend to continue to pursue domestic and international business opportunities with the support of business development consultants, key representatives, and resellers. We plan to grow our revenues through increased direct sales to militaries and large commercial and defense-related companies that desire to integrate our communication technologies into their product offerings. This includes building on fiscal 2020 domestic defense sales by pursuing further U.S. military opportunities. We also plan to pursue mass notification, government, law enforcement, fire rescue, homeland and international security, private and commercial security, border security, maritime security, and wildlife preservation business opportunities. In addition to the matters above, we are authorized for the performance of services and provision of goods pursuant to Delaware General Corporation Law.

 

In March 2020, the World Health Organization ("WHO") classified the COVID-19 outbreak as a pandemic. While the impact of the COVID-19 pandemic did not have a material adverse effect on our financial position or results of operations for the three months ended March 31, 2021, we monitor the developments and assess areas where there is potential for our business to be impacted. A significant portion of our sales force is working remotely, which could, among other things, negatively impact our ability to engage in sales-related initiatives, or efficiently conduct day-to-day operations. Other businesses and governments with which we engage are likely operating under similar restrictions and experiencing disruptions, which may create obstacles in the coordination of business activities, including the negotiation and fulfillment of orders. Disruptions in the supply chain could negatively impact our ability to source materials or manufacture and distribute products. While we do not currently anticipate a material reduction in demand for our commercialized products, we could experience a decrease in new orders, which could negatively impact our revenues and reduce our liquidity and cash flows. Growth in revenue could also be impeded by these factors. The financial markets have been subject to significant volatility that could impact our ability to enter into, modify, and negotiate favorable terms and conditions relative to equity and debt financing activities. We have $18.5 million in cash and cash equivalents as of March 31, 2021, which we believe provides sufficient capital to fund our operations for at least the next twelve months and withstand the potential near-term consequences of the pandemic, although liquidity constraints and access to capital markets could adversely impact our liquidity and warrant changes to our investment strategy. While we have not yet experienced a material impact, the full magnitude of the pandemic cannot be measured at this time, and therefore, any of the aforementioned circumstances, as well as other factors, may cause our results of operations to vary substantially from year to year and quarter to quarter.

 

Based on various standards published to date, we believe the work our associates perform is critical, essential and life sustaining. We are taking a variety of measures to promote the safety and security of our employees while ensuring the availability and functionality of our critical infrastructure. We are following Center for Disease Control guidelines to reduce the transmission of COVID-19, such as the imposition of travel restrictions, cancellation of events, the promotion of social distancing, the adoption of work-from-home arrangements, and limiting access to our facilities. Some or all of these policies and initiatives could impact our operations. In addition, the following events related to the COVID-19 pandemic could result in lost or delayed revenue to the Company: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic, or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; unforeseen deviations from customers or foreign governments restricting the ability to do business; and, limitations on the ability of our customers to pay us on a timely basis, if at all.

 

A large number of components and sub-assemblies produced by outside suppliers within our supply chain are produced within 50 miles of our facility. We source a small amount of component parts from suppliers in China. It is also likely that some of our suppliers source parts in China. The COVID-19 pandemic has adversely impacted worldwide supply chains and the ability to obtain sufficient amounts of component parts, including semiconductor chips and integrated circuits, resins, coating and other equipment and components. Negative impacts on our supply change could have a material adverse effect on our business. We are in contact with our suppliers and evaluating what impact, if any, may result from COVID-19.

 

Critical Accounting Policies

 

We have identified a number of accounting policies as critical to our business operations and the understanding of our results of operations. These are described in our consolidated financial statements located in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended September 30, 2020. The impact and any associated risks related to these policies on our business operations is discussed below and throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results.

 

The methods, estimates and judgments we use in applying our accounting policies, in conformity with U.S. generally accepted accounting principles, have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

 

27

 

Comparison of Results of Operations for the Three Months Ended March 31, 2021 and 2020 (in thousands)

 

   

Three Months Ended

                 
   

March 31, 2021

   

March 31, 2020

                 
           

% of

           

% of

                 
           

Total

           

Total

   

Fav(Unfav)

 
   

Amount

   

Revenue

   

Amount

   

Revenue

   

Amount

   

%

 

Revenues:

                                               

Product sales

  $ 10,131       89.6 %   $ 7,553       91.3 %   $ 2,578       34.1 %

Contract and other

    1,170       10.4 %     723       8.7 %     447       61.8 %

Total revenues

    11,301       100.0 %     8,276       100.0 %     3,025       36.6 %
                                                 

Cost of revenues

    5,964       52.8 %     4,266       51.5 %     (1,698 )     (39.8 %)

Gross Profit

    5,337       47.2 %     4,010       48.5 %     1,327       33.1 %
                                                 

Operating expenses

                                               

Selling, general and administrative

    3,824       33.8 %     2,732       33.0 %     (1,092 )     (40.0 %)

Research and development

    960       8.5 %     949       11.5 %     (11 )     (1.2 %)

Total operating expenses

    4,784       42.3 %     3,681       44.5 %     (1,103 )     (30.0 %)
                                                 

Income from operations

    553       4.9 %     329       4.0 %     224       68.1 %
                                                 

Other income (expense)

    (8 )     (0.1 %)     70       0.8 %     (78 )     (111.4 %)
                                                 

Income before income taxes

    545       4.8 %     399       4.8 %     146       36.6 %

Income tax expense

    283       2.5 %     97       1.2 %     (186 )     (191.8 %)

Net income

  $ 262       2.3 %   $ 302       3.6 %   $ (40 )     (13.2 %)
                                                 

Net revenue

                                               

Hardware

  $ 10,625       94.0 %